All Stories

  1. Serum Soluble Low-Density Lipoprotein Receptor-Related Protein 1 (sLRP1) is Negatively Associated With Functional Outcome Improvement From 3 to 12 Months After Acute Ischemic Stroke
  2. Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy—a phase 2 randomized trial
  3. Intravenous tirofiban following endovascular therapy for patients with acute large vessel occlusion stroke
  4. Assessment of perivascular adipose tissue attenuation using dual-layer spectral-detector CTA for identification of symptomatic carotid plaques
  5. Enhancement of Tenecteplase Thrombolytic Actions Ex Vivo and In Vivo by Deoxyribonuclease I
  6. Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis without Adjacent Branch Atheromatous Disease: A Randomized Trial with Patients Selected by Using Three-Dimensional Rotational Angiography
  7. Enlarged translesional pressure gradient drives recruitment of leptomeningeal collaterals in medically treated patients with symptomatic middle cerebral artery stenosis
  8. Associations of cerebral perfusion with infarct patterns and early neurological outcomes in symptomatic intracranial atherosclerotic stenosis
  9. Is invasive fractional flow measurement accurate in intracranial stenosis? A computational simulation study
  10. Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke
  11. Thrombolytic agents, more options, more challenges
  12. Associations of Soluble Serum Stimulation‐2 With Functional Outcomes and Death at 1 Year in Acute Ischemic Stroke: A Prospective Cohort Study
  13. Clinical Severity and Outcomes in Large Infarcts With Endovascular Therapy: A Post Hoc Analysis of the ANGEL-ASPECT Trial
  14. Association between serum levels of insulin-like growth factor-binding proteins at admission and outcomes at 3 months after acute ischemic stroke
  15. Stroke Mechanisms in Intracranial Atherosclerotic Disease: A Modified Classification System and Clinical Implications
  16. Endovascular therapy for large ischemic stroke in directly admitted versus transferred patients: A secondary analysis
  17. Collaterals and outcomes after endovascular treatment in acute large vessel occlusion: Disparity by stroke etiologies
  18. COVID-19 vaccination and cerebral small vessel disease progression—A prospective cohort study
  19. Abstract WP270: Prognostic Factors Associated with Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis
  20. Evaluation of Intensive Statins and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Intracranial Artery Plaque Stability: A Prospective Single‐Arm Study
  21. The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy
  22. Chinese Stroke Association guidelines on emergency stroke unit
  23. Ischemic core volume is associated with hemorrhagic transformation post endovascular thrombectomy
  24. More severe cerebral small vessel disease associated with poor leptomeningeal collaterals in symptomatic intracranial atherosclerotic stenosis
  25. Unveiling connections between venous disruption and cerebral small vessel disease using diffusion tensor image analysis along perivascular space (DTI-ALPS): A 7T MRI study
  26. Early vs Delayed Antihypertensive Treatment in Acute Single Subcortical Infarction
  27. Geometry of Terminal Internal Carotid Artery Bifurcation May Be Associated With Middle Cerebral Artery Plaque Ulceration: A Three-Dimensional Rotational Angiography Study
  28. Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins
  29. Thromboelastography-Guided Antiplatelet Therapy for Patients with Ischemic Cerebrocardiovascular Diseases: A Systematic Review and Meta-Analysis
  30. Dual antiplatelet therapy for ischemic stroke with intracranial arterial stenosis: a systematic review and meta-analysis
  31. Endovascular therapy in acute ischaemic stroke with large infarction with matched or mismatched clinical-radiological severities: a post-hoc analysis of the ANGEL-ASPECT trial
  32. Clinical implications of haemodynamics in symptomatic intracranial atherosclerotic stenosis by computational fluid dynamics modelling: a systematic review
  33. Comparison of outcomes between stent retriever combined with contact aspiration versus contact aspiration alone in patients without hyperdense artery sign/susceptibility vessel sign
  34. Deviation From Personalized Blood Pressure Targets Correlates With Worse Outcome After Successful Recanalization
  35. Current and Future Treatments of Vascular Cognitive Impairment
  36. Serum heme oxygenase‐1 level predicts clinical outcome after acute ischemic stroke
  37. Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants
  38. METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients
  39. Editorial: Intracranial atherosclerotic disease: epidemiology, imaging, treatment and prognosis, volume II
  40. Cerebral hemodynamics and stroke risks in symptomatic intracranial atherosclerotic stenosis with internal versus cortical borderzone infarcts: A computational fluid dynamics study
  41. Hemodynamic significance of intracranial atherosclerotic disease and ipsilateral imaging markers of cerebral small vessel disease
  42. Development of a nomogram-based model combining intra- and peritumoral ultrasound radiomics with clinical features for differentiating benign from malignant in Breast Imaging Reporting and Data System category 3–5 nodules
  43. Association of calcium channel blockers with lower incidence of intracranial aneurysm rupture and growth in hypertensive patients
  44. Neuroimaging anomalies in asymptomatic middle cerebral artery steno-occlusive disease with normal-appearing white matter
  45. Deviation from Personalized Blood Pressure Targets Correlates with Worse Outcome after Successful Recanalization
  46. Association of Alternative Anticoagulation Strategies and Outcomes in Patients With Ischemic Stroke While Taking a Direct Oral Anticoagulant
  47. Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy
  48. Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications
  49. Cerebral Hemodynamics Underlying Artery-to-Artery Embolism in Symptomatic Intracranial Atherosclerotic Disease
  50. Abstract TP181: Identification Of Hub Genes In Endothelial Cells Under Oscillatory Flow
  51. Abstract WMP84: Symptomatic Intracranial Atherosclerotic Plaques: Different Morphological Features In The Anterior Versus Posterior Circulation
  52. Case report: A rare case of massive peripheral nerve melanotic schwannoma and review of the literature
  53. Good collaterals and better outcomes after EVT for basilar artery occlusion: a systematic review and meta-analysis
  54. Editorial: minor stroke is not minor
  55. Effects of stent shape on focal hemodynamics in intracranial atherosclerotic stenosis: A simulation study with computational fluid dynamics modeling
  56. Clinically Ineffective Reperfusion After Endovascular Therapy in Acute Ischemic Stroke
  57. Associations of Hematological and Biochemical Markers with Intracranial Atherosclerotic Stenosis in Stroke-free Populations: A Systematic Review and Meta-analysis of Observational Studies
  58. Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis
  59. The Mechanism and Role of N6-Methyladenosine (m6A) Modification in Atherosclerosis and Atherosclerotic Diseases
  60. Increased serum uric acid level is associated with better outcome after endovascular treatment for acute ischemic stroke—a prospective cohort study
  61. Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamics
  62. Arterial blood gas analysis aids early differential diagnosis and treatment of primary and secondary hypokalaemic periodic paralysis
  63. Bacterial Signatures of Cerebral Thrombi in Large Vessel Occlusion Stroke
  64. Collateral Flow in Intracranial Atherosclerotic Disease
  65. Causal Relations between Exposome and Stroke: A Mendelian Randomization Study
  66. Hemodynamics Features of Symptomatic Intracranial Atherosclerotic Disease Associated with Severity of Ipsilateral Cerebral Small Vessel Disease (P1-1.Virtual)
  67. Small vessel disease burden may not portend unfavorable outcome after thrombectomy for acute large vessel occlusion
  68. Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management
  69. Validation of external and internal exposome of the findings associated to cerebral small vessel disease: A Mendelian randomization study
  70. Stability of unruptured intracranial aneurysms in the anterior circulation: nomogram models for risk assessment
  71. Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
  72. Genome sequencing reveals the role of rare genomic variants in Chinese patients with symptomatic intracranial atherosclerotic disease
  73. Editorial: Intracranial Atherosclerotic Disease: Epidemiology, Imaging, Treatment and Prognosis
  74. Comparison of Newtonian and Non-newtonian Fluid Models in Blood Flow Simulation in Patients With Intracranial Arterial Stenosis
  75. A prediction of hematoma expansion in hemorrhagic patients using a novel dual-modal machine learning strategy
  76. Elevated Neutrophil to Lymphocyte Ratio Associated With Increased Risk of Recurrent Vascular Events in Older Minor Stroke or TIA Patients
  77. Evolving ischemic stroke subtypes in 15 years: A hospital-based observational study
  78. A Data-Driven Approach to Transfer Function Analysis for Superior Discriminative Power: Optimized Assessment of Dynamic Cerebral Autoregulation
  79. Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review
  80. Intraluminal Thrombus and Outcomes of Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Treatment
  81. Adverse Outcomes Associated With Higher Mean Blood Pressure and Greater Blood Pressure Variability Immediately After Successful Embolectomy in Those With Acute Ischemic Stroke, and the Influence of Pretreatment Collateral Circulation Status
  82. Abstract P572: Cerebral Hemodynamics Underlying Artery-To-Artery Embolism in Symptomatic Intracranial Atherosclerotic Disease
  83. Abstract P678: Elevated Neutrophil to Lymphocyte Ratio Associated With Increased Risk of Recurrent Vascular Events in Older Minor Stroke or TIA Patients
  84. Abstract P549: Total Small Vessel Disease Burden Not Associated With Functional Independence After Endovascular Treatment in Acute Ischemic Stroke Patients
  85. Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China
  86. Response by Lan et al to Letter Regarding Article, “Regional High Wall Shear Stress Associated With Stenosis Regression in Symptomatic Intracranial Atherosclerotic Disease”
  87. Intracranial Atherosclerotic Disease: Epidemiology, Imaging, Treatment and Prognosis
  88. Identifying Biomarkers Associated with Venous Infarction in Acute/Subacute Cerebral Venous Thrombosis
  89. Acute Anticoagulant Therapy for the Treatment of Acute Ischaemic Stroke and Transient Ischaemic Attack
  90. Plaque morphology in acute symptomatic intracranial atherosclerotic disease
  91. Effect of microcirculatory resistance on coronary blood flow and instantaneous wave-free ratio: A computational study
  92. Regional High Wall Shear Stress Associated With Stenosis Regression in Symptomatic Intracranial Atherosclerotic Disease
  93. Cortical Microinfarcts Associated With Worse Outcomes in Patients With Acute Ischemic Stroke Receiving Endovascular Treatment
  94. High-Degree Middle Cerebral Artery Stenosis
  95. Translesional Pressure Gradient Alters Relationship Between Blood Pressure and Recurrent Stroke in Intracranial Stenosis
  96. Hemodynamic Significance of Middle Cerebral Artery Stenosis Associated With the Severity of Ipsilateral White Matter Changes
  97. Small-vessel Vasculopathy Harboured Within Intracranial Large-artery Atherosclerosis (1123)
  98. Screening for chronic conditions with reproductive factors using a machine learning based approach
  99. Characteristics of Wall Shear Stress and Pressure of Intracranial Atherosclerosis Analyzed by a Computational Fluid Dynamics Model: A Pilot Study
  100. State-of-the-art Computational Models of Circle of Willis with Physiological Applications: a Review
  101. Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality
  102. NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
  103. Fasting glucose and HbA1c levels as risk factors for the presence of intracranial atherosclerotic stenosis
  104. Response by Feng et al to Letter Regarding Article, “Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications”
  105. Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review
  106. Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease
  107. Hemodynamics and Stroke Risk in Intracranial Atherosclerotic Disease
  108. Early Identification of High-Risk TIA or Minor Stroke Using Artificial Neural Network
  109. Risk factors for intracranial atherosclerosis: A systematic review and meta-analysis
  110. Sustaining cerebral perfusion in intracranial atherosclerotic stenosis: The roles of antegrade residual flow and leptomeningeal collateral flow
  111. Guidelines for evaluation and management of cerebral collateral circulation in ischaemic stroke 2017
  112. Collateral status as the fifth dimension: warping the time clock for endovascular treatment in acute ischaemic stroke
  113. Estimating current and long-term risks of coronary artery in silico by fractional flow reserve, wall shear stress and low-density lipoprotein filtration rate
  114. Impact of Side Branches on the Computation of Fractional Flow in Intracranial Arterial Stenosis Using the Computational Fluid Dynamics Method
  115. Translesional pressure gradient and leptomeningeal collateral status in symptomatic middle cerebral artery stenosis
  116. Antiplatelet therapy after stroke
  117. Noninvasive fractional flow in intracranial atherosclerotic stenosis: Reproducibility, limitations, and perspectives
  118. Cortical Microinfarcts in Patients with Middle Cerebral Artery Stenosis
  119. Prolonged Perfusion Predicts Recurrent Ischemic Stroke but not Transient Ischemic Attack in Patients with Symptomatic Intracranial Stenosis
  120. Combined Approach of QSAR and Docking Studies for the Design of Local Anaesthetic Agents
  121. Collateral circulation alters downstream hemodynamic stress caused by intracranial atherosclerotic stenosis
  122. Collaterals 2016: Translating the collaterome around the globe
  123. Intracranial atherosclerosis: From anatomy to pathophysiology
  124. Asia Pacific Stroke Conference 2017. Abstracts of the Annual Conference of the Asia Pacific Stroke Organization (APSO) Combined with Stroke Society of Australasia. Nanjing, China, October 26-28, 2017: Abstracts
  125. Cerebral perfusion difference between hemispheres with symptomatic and asymptomatic intracranial arterial stenosis
  126. Good collateral circulation predicts favorable outcomes in intravenous thrombolysis: a systematic review and meta-analysis
  127. The contemporary management of intracranial atherosclerotic disease
  128. Fractional Flow Assessment for the Evaluation of Intracranial Atherosclerosis: A Feasibility Study
  129. Functional assessment of cerebral artery stenosis: A pilot study based on computational fluid dynamics
  130. Diminished Signal Intensities Distal to Intracranial Arterial Stenosis on Time-of-Flight MR Angiography Might Indicate Delayed Cerebral Perfusion
  131. Hemodynamic Impact of Systolic Blood Pressure and Hematocrit Calculated by Computational Fluid Dynamics in Patients with Intracranial Atherosclerosis
  132. Impact of Collateral Status on Successful Revascularization in Endovascular Treatment: A Systematic Review and Meta-Analysis
  133. Computational fluid dynamics of computed tomography angiography to detect the hemodynamic impact of intracranial atherosclerotic stenosis
  134. Dual antiplatelet therapy in stroke and ICAS
  135. Impact of collaterals on the efficacy and safety of endovascular treatment in acute ischaemic stroke: a systematic review and meta-analysis
  136. An Unusual Complication Related to Invasive Electroencephalography Monitoring: Nonhemorrhagic Subdural Fluid Collection
  137. Response to Letter Regarding Article, “Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack: An Updated Systematic Review and Meta-Analysis”
  138. Computational Fluid Dynamics Modeling of Symptomatic Intracranial Atherosclerosis May Predict Risk of Stroke Recurrence
  139. Evaluating Intracranial Atherosclerosis Rather Than Intracranial Stenosis
  140. Magnetic Resonance Angiography Signal Intensity as a Marker of Hemodynamic Impairment in Intracranial Arterial Stenosis
  141. Interobserver Reproducibility of Signal Intensity Ratio on Magnetic Resonance Angiography for Hemodynamic Impact of Intracranial Atherosclerosis
  142. Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
  143. Signal Intensity Ratio as a Novel Measure of Hemodynamic Significance for Intracranial Atherosclerosis
  144. Association Between Metabolic Syndrome and Carotid Atherosclerosis: A Community-Based Study in Hong Kong
  145. Correlation of Large Artery Intracranial Occlusive Disease With Carotid Intima-Media Thickness and Presence of Carotid Plaque